Security key
34962G208
Forte Biosciences, Inc. - Common Stock (FBRX)
CUSIP: 34962G208
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 10,343,866
- Total 13F value
- $155,080,846
- Share change
- +391,054
- SEC-reported price per share
- $15.00
- Number of holders
- 42
- Value change
- +$6,727,909
- Number of buys
- 27
- Number of sells
- 10
- Shares outstanding
- 20,417,492
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2025
Institutions
42
Top holders
10
FBRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Forte Biosciences, Inc. SEC filings
Forte Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 34962G208
Recent filing periods:
Ownership snapshot
Top reported holders of FBRX - Forte Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TYBOURNE CAPITAL MANAGEME...
Disclosed value leader
FRED ALGER MANAGEMENT, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 10%
13D/G row: TYBOURNE CAPITAL MANAGEMENT (HK) LTD
Showing 1-6 of 15 holder rows.
Quick read
TYBOURNE CAPITAL MANAGEMENT (HK) LTD leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TYBOURNE CAPITAL MANAGEMENT (HK) LTD's linked filing trail.
Comparable ownership
Top 5
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
10%
ORBIMED ADVISORS LLC
8%
Ikarian Capital, LLC
5%
Farallon Capital Partners, L.P.
3.4%
PERCEPTIVE ADVISORS LLC
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD |
13D/G
13F
Company
|
10%
|
$13,378,307
1,268,086 shares
|
+$6,618,184 | 30 Jun 2025 |
| ORBIMED ADVISORS LLC |
13F
13D/G
Company
|
8%
from 13D/G
|
$15,476,628
1,196,955 shares
|
— | 30 Jun 2025 |
| Ikarian Capital, LLC |
13D/G
13F
Company
|
5%
|
$6,516,387
617,667 shares
|
+$89,063 | 30 Jun 2025 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
3.4%
|
$12,130
221,027 shares
|
$0 | 31 Dec 2024 |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
Company
|
2.5%
|
$1,209,840
163,935 shares
|
$0 | 31 Dec 2024 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
13D/G
Company
|
0.8%
from 13D/G
|
$758,176
58,637 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
42
Shares
10,343,866
Rows available
42
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q3 2025 Across Filers
Q3 2025 holders
42
Q3 2025 holders
42
Holder diff
0
| Investor | Q3 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend